QUIA PHARMA AB (OSTO:QUIA) Net Issuance of Preferred Stock : kr0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

QUIA PHARMA AB's net issuance of preferred for the six months ended in Dec. 2024 was kr0.00 Mil. The number is 0, which means that QUIA PHARMA AB has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

QUIA PHARMA AB's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

QUIA PHARMA AB Net Issuance of Preferred Stock Historical Data

The historical data trend for QUIA PHARMA AB's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB Net Issuance of Preferred Stock Chart

QUIA PHARMA AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

QUIA PHARMA AB Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

QUIA PHARMA AB Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

QUIA PHARMA AB Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

QUIA PHARMA AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

99B0:Germany

Address

Virdings Alle 32 B, Uppsala, SWE, 754 50

Website

https://www.quiapeg.com

QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines